{
    "nctId": "NCT02283983",
    "briefTitle": "Evaluation of Cryoprotection Induced Nail Toxicity Docetaxel Low Cumulative Dose",
    "officialTitle": "Evaluation of Cryoprotection of Nail Toxicity Induced by Docetaxel Low Cumulative Dose. Controlled, Randomized, Open, Multicentre Prospective.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 319,
    "primaryOutcomeMeasure": "Evaluation of the Occurrence of Nail Toxicity of Grade 2 of Common Toxicity Criteria for Adverse Effects V4.0 Evaluated at 8 Weeks Post Infusion of Docetaxel.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* upper age to 18 years\n* mammary adenocarcinoma nonmetastatic and histologically proven\n* wait under an adjuvant or neoadjuvant chemotherapy according to the following conventional scheme: 3 cycles of F5-Fluorouracil, epirubicin and cyclophosphamide 100 (500 or 5-Fluorouracil 600 mg / m\u00b2 J1, Epirubicin 100 mg / m\u00b2 J1, Cyclophosphamide 500 or 600 mg / m\u00b2 J1 or 3 cycles of Epiribucin and Cyclophosphamide 100) followed by 3 cycles of docetaxel, 100 mg / m\u00b2, +/- trastuzumab if Her2+++\n* Patient with the capacity/faculties to understand a newsletter and sign an informed consent\n* Patient receiving social coverage\n* Patient who can be treated and followed in the center for a period of at least one year\n* WHO scale 0 or 1\n\nExclusion Criteria:\n\n* Age below 18 years\n* Diseases of the scalp or whatever hair-showing against helmet or alopecia\n* Using pre nail resin before and per chemotherapy\n* mammary adenocarcinoma stage IV\n* Indication of docetaxel for cancer of another organ than breast\n* Treatment processing or programmed during chemotherapy with an innovative molecule being evaluated\n* Raynaud's syndrome, cold agglutinin disease, cryoglobulinemia and cryofibrinogenemia.\n* Uncontrolled severe arterial disease.\n* Presence of a device\\> grade 1 neuropathy before the start of chemotherapy\n* Patient unable to submit the protocol followed for psychological, social, family or geographical\n* Patient with an incompatible underlying disease or concomitant with the inclusion in the trial, whether psychiatric or somatic\n* Patient trust, guardianship, under legal protection measure, deprived of freedom\n* Male\n* Criteria for non randomization (before the first course of docetaxel) :\n\n  * Presence of peripheral neuropathy\\> grade 1 after the first 3 cycles of 5-Fluorouracil, epirubicin and cyclophosphamide 100.\n  * Presence of a nail or skin toxicity\\> grade 1 after 3 cycles of 5-Fluorouracil, epirubicin and cyclophosphamide 100.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}